Alerts will be sent to your verified email
Verify EmailALBERTDAVD
|
Albert David
|
Medico Remedies
|
Zim Laboratories
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceuticals
|
|||
|
R&D as a % of Total Sales
|
0.84 % | n/a | 11.0 % |
|
Financials
|
|||
|
5 yr Average ROE
|
11.47 % | 13.93 % | 7.41 % |
|
5yr average Equity Multiplier
|
1.63 | 2.07 | 1.88 |
|
5yr Average Asset Turnover Ratio
|
0.62 | 1.49 | 0.94 |
|
5yr Avg Net Profit Margin
|
11.31 % | 4.73 % | 4.15 % |
|
Price to Book
|
1.0 | 5.97 | 1.46 |
|
P/E
|
0.0 | 35.21 | 55.71 |
|
5yr Avg Cash Conversion Cycle
|
-77.77 Days | 53.33 Days | 37.07 Days |
|
Inventory Days
|
47.91 Days | 48.95 Days | 68.72 Days |
|
Days Receivable
|
27.87 Days | 129.15 Days | 99.71 Days |
|
Days Payable
|
140.35 Days | 124.28 Days | 143.26 Days |
|
5yr Average Interest Coverage Ratio
|
93.73 | 11.55 | 3.96 |
|
5yr Avg ROCE
|
14.69 % | 20.03 % | 13.52 % |
|
5yr Avg Operating Profit Margin
|
9.55 % | 7.11 % | 12.21 % |
|
5 yr average Debt to Equity
|
0.02 | 0.26 | 0.39 |
|
5yr CAGR Net Profit
|
-4.92 % | 31.26 % | 10.7 % |
|
5yr Average Return on Assets
|
7.03 % | 6.88 % | 4.02 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
62.24 % | 61.38 % | 33.26 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.25 % | -11.96 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Albert David
|
Medico Remedies
|
Zim Laboratories
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Dosage Form Break-Up
|
Dosage Form Break-Up
|
-
|
-
|
|
Customer Wise Break-Up
|
Customer Wise Break-Up
|
-
|
-
|